全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Jenny Iversen , Matthew Law ...
来源:[J].Drug and Alcohol Dependence(IF 3.141), 2019, Vol.197, pp.108-114
摘要:Abstract(#br)Background(#br)Effective targeting of harm reduction programs for people who inject drugs (PWID) requires timely and robust estimates of the size of this population. This study estimated the number of people who inject drugs on a regular basis in Australia, calc...
作者:Jenny Iversen , Libby Topp ...
来源:[J].Drug and Alcohol Dependence(IF 3.141), 2012, Vol.122 (3), pp.195-200
摘要:Abstract(#br)Background(#br)Harm associated with injecting drug use is a significant public health issue and a major cause of morbidity and mortality, with global estimates of 3 million injectors infected with HIV and 8 million living with chronic hepatitis C virus (HCV) inf...
作者:Jenny Iversen , Carolyn Day ...
来源:[J].Australian and New Zealand Journal of Public Health(IF 1.639), 2013, Vol.37 (2), pp.148-154
摘要:Abstract Background : People who inject drugs (PWID) report limited access to healthcare, and may avoid disclosing drug use. Health service utilisation was examined among participants in the Australian Needle and Syringe Program Survey (ANSPS), an annual cross‐sectional sero...
作者:... Simon Graham , Handan Wand , Jenny Iversen
来源:[J].Australian and New Zealand Journal of Public Health(IF 1.639), 2018, Vol.42 (1), pp.52-56
摘要:Abstract(#br)Objective: To examine factors associated with hepatitis C virus (HCV) infection among a national sample of Indigenous and non‐Indigenous people who inject drugs (PWID) in Australia.(#br)Methods: Respondents were recruited from Australia's Needle Syringe Program ...
作者:Jenny Iversen , Julie Bruneau ...
来源:[J].The Lancet Infectious Diseases(IF 19.966), 2018, Vol.18 (12), pp.1397-1409
摘要:Summary(#br)Background(#br)People who inject drugs (PWID) experience a high prevalence of incarceration and might be at high risk of HIV and hepatitis C virus (HCV) infection during or after incarceration. We aimed to assess whether incarceration history elevates HIV or HCV ...
作者:Jenny Iversen , Andrew Conroy ...
来源:[J].Australian and New Zealand Journal of Public Health(IF 1.639), 2008, Vol.32 (1), pp.34-37
摘要:Abstract(#br)Objective: To identify lifetime prevalence and predictors of self‐reported injecting‐related injuries and diseases (IRID) and/or injecting‐related problems (IRP) among a national cross‐sectional sample of injecting drug users.(#br)Methods: 1,961 clients of ...
作者:Jenny Iversen , Carolyn Day ...
来源:[J].Australian and New Zealand Journal of Public Health(IF 1.639), 2013, Vol.37 (2), pp.148-154
摘要:Abstract(#br)Background : People who inject drugs (PWID) report limited access to healthcare, and may avoid disclosing drug use. Health service utilisation was examined among participants in the Australian Needle and Syringe Program Survey (ANSPS), an annual cross‐sectional ...
作者:Jenny Iversen , Handan Wand ...
来源:[J].Australian and New Zealand Journal of Public Health(IF 1.639), 2011, Vol.35 (5), pp.421-426
摘要:Abstract(#br)Objective : To compare prevalence of hepatitis C virus (HCV) antibody and associated risk behaviours among Indigenous and non‐Indigenous participants in the Australian Needle and Syringe Program Survey.(#br)Methods : During 1 or 2 weeks each October from 1998 to...
作者:Jenny Iversen , Jason Grebely ...
来源:[J].International Journal of Drug Policy, 2017
摘要:Abstract(#br)Background(#br)Hepatitis C virus (HCV) infection is endemic among people who inject drugs (PWID) globally. Despite high prevalence, treatment uptake is low, with cumulative uptake <10% in most settings. This study aimed to populate the cascade of HCV testing, ca...
作者:... Handan Wand , Michael Doyle , Jenny Iversen
来源:[J].International Journal of Drug Policy, 2017
摘要:Abstract(#br)Background(#br)Research indicates that hepatitis C antibody (anti-HCV) prevalence is higher among Australian Aboriginal and Torres Strait Islander (Aboriginal) than non-Aboriginal people who inject drugs (PWID). We examined trends in demographic and drug use cha...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×